TransCure bioServices at 3rd Annual Next-Gen Immuno-Oncology Congress

Event's date
From : 14 March 2019
to : 15 March 2019
Event's place

TransCure bioServices will give a pitch at the 3rd Annual Next-Gen Immuno-Oncology Congress

Our Dir. Business Development Romain GRET and our CSOSebastien Tabruyn will be waiting you in London, from March, 14th to 15th.

TransCure bioServices gives a pitch

Attend the pitch of Sebastien Tabruyn at 3.30 pm on March 14th.

Topic of Presentation (with 3 bullet points):

  • Humanized Mouse Models for Immuno-oncology Research
  • Preclinical Oncolytic Virus Efficacy Testing
  • Immune check point inhibitor: How to validate combination therapy
  • Preclinical Immunotherapy Safety and Toxicity Assessment: Case study with CAR-T cells

Meet our Director, Business Development and CSO by requesting a meeting:

Request a meeting


Who are we?

TransCure bioService is a pre-clinical CRO dedicated to the evaluation of treatments for HIV, immuno-oncology, and inflammations diseases. Our team elaborates unique Research & Development (R&D) and fee-for-service platforms, called the Full Human Immune System Mouse Models (hu-mouse models). Therefore, customers access these full services (protocol design, data collection and analysis) in our BSL-2 and BSL-3 animal and laboratory facilities on a very attractive fee-for-service basis.

 Request a meeting with our Team in London

Request a meeting

Share this!